Taiwania led APrevent Medical's $6 million Series D funding round.
APrevent Medical is a medical device company focused on innovative solutions for voice and speech disorders, including the APrevent® VOIS vocal implant system and the AiSpeak speech conversion platform
APrevent Medical is a medical device company focused on innovative solutions for voice and speech disorders, including the APrevent® VOIS vocal implant system and the AiSpeak speech conversion platform.